Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Mar;46(3):892-5.
doi: 10.1128/AAC.46.3.892-895.2002.

In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain

Carmen Betriu  1 , Iciar Rodríguez-Avial, Blas Ali Sánchez, María Gómez, Juan Alvarez, Juan J Picazo; Spanish Group of Tigecycline
Affiliations

In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain

Carmen Betriu et al. Antimicrob Agents Chemother. 2002 Mar.

Abstract

The antimicrobial activities of tigecycline (GAR-936) were compared with those of other agents against 1,087 strains recently isolated in 12 Spanish medical centers. Tigecycline showed activity against a wide spectrum of aerobic and anaerobic bacteria, including strains such as methicillin-resistant Staphylococcus aureus, coagulase-negative staphylococci, penicillin-resistant Streptococcus pneumoniae, Enterococcus faecium, Acinetobacter baumannii, and Stenotrophomonas maltophilia.

PubMed Disclaimer

References

    1. Aldridge, K., D. Ashcraft, K. Cambre, C. Pierson, S. Jenkins, and J. Rosenblatt. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:1238-1243. - PMC - PubMed
    1. Betriu, C., C. Cabronero, M. Gomez, and J. Picazo. 1992. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Eur. J. Clin. Microbiol. Infect. Dis. 11:352-356. - PubMed
    1. Boucher, H., C. Wennersten, and G. Eliopoulos. 2000. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrob. Agents Chemother. 44:2225-2229. - PMC - PubMed
    1. Chen, D. K., A. McGeer, J. C. de Azavedo, and D. E. Low. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:233-239. - PubMed
    1. Edlund, C., and C. Nord. 2000. In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline. Clin. Microbiol. Infect. 6:159-163. - PubMed

Publication types

MeSH terms

LinkOut - more resources